FDA Director Updates Congress on its Medical Device Reform Efforts
In testimony before Congress on April 13, 2011, the FDA's Director for Medical Devices, Dr. William Maisel, discussed the agency's efforts to reform the medical device programs, including the FDA's 510(k) action plan for these products, its Medical Device Innovation…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Initiative, post market surveillance activities, adverse event reporting, and device recall improvements, among other activities.